Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Structure-activity relationship of orally potent tripeptide-based HIV protease inhibitors containing hydroxymethylcarbonyl isostere.
Mimoto T, Hattori N, Takaku H, Kisanuki S, Fukazawa T, Terashima K, Kato R, Nojima S, Misawa S, Ueno T, Imai J, Enomoto H, Tanaka S, Sakikawa H, Shintani M, Hayashi H, Kiso Y. Mimoto T, et al. Among authors: hattori n. Chem Pharm Bull (Tokyo). 2000 Sep;48(9):1310-26. doi: 10.1248/cpb.48.1310. Chem Pharm Bull (Tokyo). 2000. PMID: 10993230
Rational design and synthesis of a novel class of active site-targeted HIV protease inhibitors containing a hydroxymethylcarbonyl isostere. Use of phenylnorstatine or allophenylnorstatine as a transition-state mimic.
Mimoto T, Imai J, Tanaka S, Hattori N, Takahashi O, Kisanuki S, Nagano Y, Shintani M, Hayashi H, Sakikawa H, et al. Mimoto T, et al. Among authors: hattori n. Chem Pharm Bull (Tokyo). 1991 Sep;39(9):2465-7. doi: 10.1248/cpb.39.2465. Chem Pharm Bull (Tokyo). 1991. PMID: 1804562
Discovery and in vitro and in vivo profiles of N-ethyl-N-[2-[3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl]ethyl]-2-(2H-1,2,3-triazol-2-yl)-benzamide as a novel class of dual orexin receptor antagonist.
Suzuki R, Nozawa D, Futamura A, Nishikawa-Shimono R, Abe M, Hattori N, Ohta H, Araki Y, Kambe D, Ohmichi M, Tokura S, Aoki T, Ohtake N, Kawamoto H. Suzuki R, et al. Among authors: hattori n. Bioorg Med Chem. 2015 Mar 15;23(6):1260-75. doi: 10.1016/j.bmc.2015.01.044. Epub 2015 Feb 10. Bioorg Med Chem. 2015. PMID: 25693785
Trends in prior antithrombotic medication and risk of in-hospital mortality after spontaneous intracerebral hemorrhage: the J-ICH registry.
Ueno H, Tokugawa J, Saito R, Yamashiro K, Tsutsumi S, Yamamoto M, Ueno Y, Mieno M, Yamamoto T, Hishii M, Yasumoto Y, Maruki C, Kondo A, Urabe T, Hattori N, Arai H, Tanaka R; Juntendo Registry of Spontaneous Intracerebral Hemorrhage Study Group. Ueno H, et al. Among authors: hattori n. Sci Rep. 2024 May 25;14(1):12009. doi: 10.1038/s41598-024-62717-5. Sci Rep. 2024. PMID: 38796624 Free article.
Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER study.
Nishikawa N, Hatano T, Nishioka K, Ueno SI, Saiki S, Nakamura R, Yoritaka A, Ogawa T, Shimo Y, Sako W, Shimura H, Furukawa Y, Kamei T, Ishida T, Hattori N; J-SILVER study group. Nishikawa N, et al. Among authors: hattori n. J Neurol Sci. 2024 May 17;461:123051. doi: 10.1016/j.jns.2024.123051. Online ahead of print. J Neurol Sci. 2024. PMID: 38788287 Free article.
2,460 results